GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ICARES Medicus Inc (ROCO:6612) » Definitions » Price-to-Free-Cash-Flow

ICARES Medicus (ROCO:6612) Price-to-Free-Cash-Flow : N/A (As of Jun. 10, 2024)


View and export this data going back to 2016. Start your Free Trial

What is ICARES Medicus Price-to-Free-Cash-Flow?

As of today (2024-06-10), ICARES Medicus's share price is NT$140.00. ICARES Medicus's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 was NT$-3.57. Hence, ICARES Medicus's Price-to-Free-Cash-Flow Ratio for today is N/A.

The historical rank and industry rank for ICARES Medicus's Price-to-Free-Cash-Flow or its related term are showing as below:

During the past 11 years, ICARES Medicus's highest Price-to-Free-Cash-Flow Ratio was 886.10. The lowest was 21.29. And the median was 45.69.

ROCO:6612's Price-to-Free-Cash-Flow is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 34.12
* Ranked among companies with meaningful Price-to-Free-Cash-Flow only.

ICARES Medicus's Free Cash Flow per Share for the three months ended in Mar. 2024 was NT$-0.33. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was NT$-3.57.

During the past 12 months, the average Free Cash Flow per Share Growth Rate of ICARES Medicus was -224.40% per year.

During the past 11 years, ICARES Medicus's highest 3-Year average Free Cash Flow per Share Growth Rate was 14.00% per year. The lowest was -17.80% per year. And the median was -1.90% per year.


ICARES Medicus Price-to-Free-Cash-Flow Historical Data

The historical data trend for ICARES Medicus's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ICARES Medicus Price-to-Free-Cash-Flow Chart

ICARES Medicus Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 34.83 72.34 29.11 -

ICARES Medicus Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 44.61 329.11 - - -

Competitive Comparison of ICARES Medicus's Price-to-Free-Cash-Flow

For the Medical Instruments & Supplies subindustry, ICARES Medicus's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ICARES Medicus's Price-to-Free-Cash-Flow Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, ICARES Medicus's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where ICARES Medicus's Price-to-Free-Cash-Flow falls into.



ICARES Medicus Price-to-Free-Cash-Flow Calculation

ICARES Medicus's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=140.00/-3.565
=N/A

ICARES Medicus's Share Price of today is NT$140.00.
ICARES Medicus's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$-3.57.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

ICARES Medicus  (ROCO:6612) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


ICARES Medicus Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of ICARES Medicus's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


ICARES Medicus (ROCO:6612) Business Description

Traded in Other Exchanges
N/A
Address
Number 16, Sec.2, Sheng Yi Road, 4th Floor, Hsinchu County, Zhubei, TWN, 30261
ICARES Medicus Inc is engaged in providing high-grade nanomedical lubricious coatings and various surface treatments for implantable or interventional medical devices and designing, development, manufacturing and sale of intraocular lenses and nanomedical devices. Its products include Artificial Lens.

ICARES Medicus (ROCO:6612) Headlines

No Headlines